HC Wainwright & Co. Reiterates Buy on First Wave BioPharma

HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy.

byBenzinga Newsdesk

January 26, 2023

1 minute read

HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy.

2022’s Worst Performing Hedge Fund Saw Negative 56% Returns, Has These Stocks To Blame

By AJ Fabino

January 11, 3:43 PM

Last year was one of the worst years for equities, with all three major indexes having their worst year since 2008, cutting a three-year winning streak.

AMZN

Notable Snowflake Insider Trades $19.42 Million In Company Stock

By Benzinga Insights

September 13, 10:55 AM

Michael Scarpelli, Chief Financial Officer at Snowflake (NYSE:SNOW), made a large buy and sell of company shares on September 8, according to a new SEC filing.

SNOW

Barclays Upgrades First Solar to Equal-Weight, Raises Price Target to $162

By Benzinga Newsdesk

November 1, 6:16 AM

Barclays analyst Christine Cho upgrades First Solar (NASDAQ:FSLR) from Underweight to Equal-Weight and raises the price target from $89 to $162.

FSLR

Fusion Fuel and Electus Energy Announced Exclusive Agreement to Develop a 75 MW Green Hydrogen Project in Bakersfield, California

By Charles Gross

November 28, 5:45 AM

Fusion Fuel (Nasdaq: HTOO) and Electus Energy (‘Electus') announced today that the two companies have entered into an exclusive joint venture agreement to develop a large-scale green hydrogen project in Bakersfield, California.

HTOO

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma

Related Posts

2022’s Worst Performing Hedge Fund Saw Negative 56% Returns, Has These Stocks To Blame

Notable Snowflake Insider Trades $19.42 Million In Company Stock

Barclays Upgrades First Solar to Equal-Weight, Raises Price Target to $162

Fusion Fuel and Electus Energy Announced Exclusive Agreement to Develop a 75 MW Green Hydrogen Project in Bakersfield, California